Disease-modifying therapies for relapsing/active secondary progressive multiple sclerosis – a review of population-specific evidence from randomized clinical trials

Antonios Bayas, Sven G. Meuth, Refik Pul et al.|Therapeutic Advances in Neurological Disorders|2023

Cited by 25